EP3860592 - OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.02.2024 Database last updated on 19.10.2024 | |
Former | Request for examination was made Status updated on 09.07.2021 | ||
Former | The international publication has been made Status updated on 06.06.2020 | Most recent event Tooltip | 16.02.2024 | Application deemed to be withdrawn | published on 20.03.2024 [2024/12] | Applicant(s) | For all designated states CELLIX BIO PRIVATE LIMITED Plot No. 1177B Road No. 56, Jubilee Hills Hyderabad 500033 / IN | [2021/32] | Inventor(s) | 01 /
KANDULA, Mahesh 11-61, East Godavari District G. Medapadu 533434 / IN | [2021/32] | Representative(s) | Isarpatent Patent- und Rechtsanwälte Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31 80801 München / DE | [2021/32] | Application number, filing date | 19889347.1 | 23.11.2019 | [2021/32] | WO2019IB60094 | Priority number, date | IN201841044540 | 26.11.2018 Original published format: IN201841044540 | IN201941001491 | 12.01.2019 Original published format: IN201941001491 | [2021/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020109957 | Date: | 04.06.2020 | Language: | EN | [2020/23] | Type: | A1 Application with search report | No.: | EP3860592 | Date: | 11.08.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.06.2020 takes the place of the publication of the European patent application. | [2021/32] | Search report(s) | International search report - published on: | IN | 04.06.2020 | (Supplementary) European search report - dispatched on: | EP | 22.03.2023 | Classification | IPC: | A61K9/00, A61K9/10, A61K31/498, A61K31/4178, A61K31/385, A61K31/4174, A61P17/00, A61P27/00, A61P27/04, C07D233/22 | [2023/03] | CPC: |
C07D233/22 (EP,IL,KR,US);
A61K31/4174 (KR);
A61P11/00 (KR);
A61P27/02 (KR);
C07C53/126 (US);
C07C65/10 (KR);
C07D213/55 (US);
C07D213/56 (US);
C07D339/04 (US);
C07D401/02 (KR);
C07D403/12 (KR);
C07D409/02 (KR);
C07D493/22 (KR)
(-)
|
Former IPC [2021/32] | A61K31/4174, A61K9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/32] | Title | German: | OPHTHALMISCHE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON HAUT- UND AUGENKRANKHEITEN | [2021/32] | English: | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISEASES AND EYE DISEASES | [2021/32] | French: | COMPOSITIONS OPHTALMIQUES ET MÉTHODES DE TRAITEMENT DE MALADIES OCULAIRES ET DE MALADIES CUTANÉES | [2021/32] | Entry into regional phase | 07.05.2021 | National basic fee paid | 07.05.2021 | Search fee paid | 07.05.2021 | Designation fee(s) paid | 07.05.2021 | Examination fee paid | Examination procedure | 07.05.2021 | Examination requested [2021/32] | 17.11.2021 | Amendment by applicant (claims and/or description) | 24.10.2023 | Application deemed to be withdrawn, date of legal effect [2024/12] | 14.11.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/12] | Fees paid | Renewal fee | 30.11.2021 | Renewal fee patent year 03 | 30.11.2022 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.11.2023 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2006084174 (YU RUEY J [US], et al) [I] 1,5-8 * examples 9-11; claims 1-34,44 *; | [A]US2009124683 (GARNER WILLIAM [US], et al) [A] 1,5-8 * paragraphs [0033] , [0051]; claims 18,19 *; | [XY]US2013079379 (SHANLER STUART D [US], et al) [X] 1,5-7 * paragraphs [0101] , [0139] , [0146]; claim 17 * [Y] 1,5-8; | [XY]US2014113947 (SHANLER STUART D [US], et al) [X] 1,5-7 * paragraphs [0058] , [0079]; claim 1 * [Y] 1,5-8; | [I]WO2014104784 (CHONG KUN DANG PHARM CORP [KR]) [I] 1,5-8 * page 10, line 10; figure 1; claims 8,17,24-30; table 2 *; | [XI]WO2014158119 (SANTA FARMA İLAÇ SANAYİ A Ş [TR]) [X] 1,5-7 * example -; claim 4 *[I] 1,5-8 | International search | [X]WO2012118704 (VOOM LLC [US], et al) [X] 1, 5-7 and 17 * pages 11-16, claims 1-10 *; | [X]US2013079379 (SHANLER STUART D [US], et al) [X] 1, 5-7 and 17* abstract, paragraphs- [0101], [0122]-[0124], [0130], [0133], [0138]-[0140], [0146], [0156] *; | [X]US2014113947 (SHANLER STUART D [US], et al) [X] 1, 5-7 and 17 * paragraphs- [0078]-[0090], calims 1-2 * |